Dose Escalation Study to Evaluate the Safety and Antiviral Activity of Val-mCyd in Adults With Chronic Hepatitis C
Clinical trial NCT00227435 · COMPLETED
Trial details
- NCT number
- NCT00227435
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-02-01
- Primary completion
- 2004-07-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.